NGM Biopharmaceuticals, Inc. EBITDA 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
---|---|
2023 | $-155 |
2022 | $-162 |
2021 | $-111 |
2020 | $-97 |
2019 | $-43 |
2018 | $2 |
2017 | $-11 |
NGM Biopharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
---|---|
2023-12-31 | $-30 |
2023-09-30 | $-32 |
2023-06-30 | $-42 |
2023-03-31 | $-51 |
2022-12-31 | $-39 |
2022-09-30 | $-48 |
2022-06-30 | $-45 |
2022-03-31 | $-31 |
2021-12-31 | $-25 |
2021-09-30 | $-26 |
2021-06-30 | $-34 |
2021-03-31 | $-26 |
2020-12-31 | $-26 |
2020-09-30 | $-28 |
2020-06-30 | $-24 |
2020-03-31 | $-19 |
2019-12-31 | $-16 |
2019-09-30 | $-11 |
2019-06-30 | $-8 |
2019-03-31 | $-8 |
2018-12-31 | $15 |
2018-09-30 | $-7 |
2018-06-30 | $-3 |
2018-03-31 | $-3 |